Skip to main content

Table 2 Relative intensity of the four peptides in MM different groups and healthy control

From: Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma

Peaks (Da)

ND group (n = 62)a

HC group (n = 64)

CR&VGPR group (n = 38)

RR group (n = 43)

2660.65

47.73 ± 28.41

24.58 ± 11.3

26.73 ± 12.43

46.37 ± 27.54

2900.4

4.96 ± 2.12

1.31 ± 0.35

1.44 ± 0.38

5.08 ± 2.58

3315.96

7.48 ± 5.08

2.08 ± 1.16

1.94 ± 0.65

8.55 ± 5.78

7763.24

2.09 ± 1.69

8.86 ± 3.25

7.63 ± 2.01

1.91 ± 1.25

  1. a“n” stands for the number of patients
Back to article page

Clinical Proteomics

ISSN: 1559-0275